This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
A Novel Peptide, HS1002, Enhances Antitumor Activity via Dual Targeting of the GnRH Receptor and Human Telomerase Reverse Transcriptase in Prostate Cancer Cells.
MedComm, 7(3), e70630
Citation
Park, Jae Hyeon; Lee, Joo Chan; Sharma, Swati; Jiang, Chunxue; Lee, Haeun; Park, Hyun-Ju; Kim, Hyung Sik. (2026). A Novel Peptide, HS1002, Enhances Antitumor Activity via Dual Targeting of the GnRH Receptor and Human Telomerase Reverse Transcriptase in Prostate Cancer Cells.. MedComm, 7(3), e70630. https://doi.org/10.1002/mco2.70630